| 000 | 01363 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514051632.0 | ||
| 264 | 0 | _c20021213 | |
| 008 | 200212s 0 0 eng d | ||
| 022 | _a0098-1532 | ||
| 024 | 7 |
_a10.1002/mpo.10105 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTrobaugh-Lotrario, Angela D | |
| 245 | 0 | 0 |
_aVincristine neurotoxicity in the presence of hereditary neuropathy. _h[electronic resource] |
| 260 |
_bMedical and pediatric oncology _cJan 2003 |
||
| 300 |
_a39-43 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
| 650 | 0 | 4 |
_aCharcot-Marie-Tooth Disease _xcomplications |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 |
_aGuillain-Barre Syndrome _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle Weakness _xchemically induced |
| 650 | 0 | 4 |
_aNeural Conduction _xdrug effects |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdiagnosis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aSmith, Amy A | |
| 700 | 1 | _aOdom, Lorrie F | |
| 773 | 0 |
_tMedical and pediatric oncology _gvol. 40 _gno. 1 _gp. 39-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/mpo.10105 _zAvailable from publisher's website |
| 999 |
_c12233908 _d12233908 |
||